Skip to main content
AMB Express
Fig. 5 | AMB Express

Fig. 5

From: Synthesis of ellagic acid glucoside using glucansucrase from Leuconostoc and characterization of this glucoside as a functional neuroprotective agent

Fig. 5Fig. 5

Functional evaluation of EA and EAG using SH-SY5Y cells. The morphological photograph showing that EA and EAG are pretreated to prevent cell damage from glutamate treatment (a). Cell viability according to treatment with 1–100 μM of EA or EAG compared with only buffer treatment. As positive controls, 1 and 10 μM of theanine were treated (b). Cortisol content in the cells treated with 1 or 10 μM theanine, EA, or EAG before treatment of glutamate (c). Inhibition rate of AChE enzyme after treatment with 100 mM glutamate followed by treatment with 10 μM tacrine, 50 or 100 μM of EA or EAG (d). Mean with same letter in each column are not significantly different by Duncan’s multiple range test (p < 0.05)

Back to article page